price
About
Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus, New Jersey, is a premier provider of diagnostic testing, information, and related services, serving clients both domestically and internationally. Its core business involves the development and provision of diverse diagnostic information services, such as routine, advanced clinical, and anatomic pathology testing. While primarily operating under the Quest Diagnostics brand, it also leverages specialized identities like AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum to reach a broad spectrum of clients. Its extensive client base includes patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and other direct healthcare entities. Delivery of these services is facilitated through a robust network comprising laboratories, patient service centers, in-office phlebotomists, call centers, and mobile health professionals including paramedics and nurses. Additionally, the company provides risk assessment services for the life insurance industry and offers comprehensive information technology solutions to healthcare organizations and clinicians.
- Stock ticker
- DGX
- Company
- Quest Diagnostics Incorporated
- Industry
- Healthcare
- Category
- US
- Stock split / reverse split
- 12
- Launch date
- Dec 17, 1996
- Listed exchange
- NYSE
Financials
Summary: DGX reported Revenue of 3.04B (+10.21%), beating expectations; EPS of 3.12 (+19.08%), beating expectations.
Dividends
DGX conversion tables
 |  |
|---|---|
| 0.5 DGX | 118.15 USD |
| 1 DGX | 236.31 USD |
| 5 DGX | 1,181.56 USD |
| 10 DGX | 2,363.12 USD |
| |
|---|---|
| 0.5 USD | 0.0021158 DGX |
| 1 USD | 0.0042317 DGX |
| 5 USD | 0.021158 DGX |
| 10 USD | 0.042317 DGX |
More to explore
FAQ
DGX is trading at $236.31, +1.87% over the last 24 hours. Track live moves on the price chart at the top of this page.
The DGX stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. DGX is currently trading at $236.31, +1.87% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on DGX price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the Healthcare sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. DGX's P/E ratio is currently 24.96 — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from DGX; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against DGX's historical range and other companies in the Healthcare sector.
Quest Diagnostics Incorporated's market cap is currently 25.95B USD. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.